ARCHIVES

Banned Investigator Plans To Resume Clinical Trials Role

This article is from The Cancer Letter archive.

Vol. 16 No. 32 | August 10, 1990

Download PDF Visit The Full Archive

Related Articles

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

U.S. Cancer Mortality Declines Overall; Incidence, Death, For 12 Cancers Rising

June 8, 2001

NCI R01 Payline Falls To 12th Percentile In Fifth Year Of No-Growth Budgets.

March 7, 2008

Rauscher Mammography Guidelines Would Limit Annual Use To Members Of High Risk Group

August 13, 1976

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980